Cabozantinib,Nivolumab,Ipilimumab
BMS
['rcc,(-irccs),(-srcc),(-urcc)']
manuela schmidinger, md; eloquently discussed 3 non-clear cell carcinoma abstract to make it clear! why is the treatment of non-ccrcc still a challenge in 2023? #asco23 
On the road! Medical Oncologist & Prof @AnkaraUni | GU cancer expert  🔬| Diversity & Equity 📢 Advocate 💫  🌍 #Oncology #GenitourinaryCancer